Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa
- PMID: 32860699
- PMCID: PMC7499501
- DOI: 10.1093/cid/ciaa1198
Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa
Erratum in
-
Erratum to: Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.Clin Infect Dis. 2022 Apr 9;74(7):1321. doi: 10.1093/cid/ciab803. Clin Infect Dis. 2022. PMID: 35297478 Free PMC article. No abstract available.
Abstract
Background: Risk factors for coronavirus disease 2019 (COVID-19) death in sub-Saharan Africa and the effects of human immunodeficiency virus (HIV) and tuberculosis on COVID-19 outcomes are unknown.
Methods: We conducted a population cohort study using linked data from adults attending public-sector health facilities in the Western Cape, South Africa. We used Cox proportional hazards models, adjusted for age, sex, location, and comorbidities, to examine the associations between HIV, tuberculosis, and COVID-19 death from 1 March to 9 June 2020 among (1) public-sector "active patients" (≥1 visit in the 3 years before March 2020); (2) laboratory-diagnosed COVID-19 cases; and (3) hospitalized COVID-19 cases. We calculated the standardized mortality ratio (SMR) for COVID-19, comparing adults living with and without HIV using modeled population estimates.
Results: Among 3 460 932 patients (16% living with HIV), 22 308 were diagnosed with COVID-19, of whom 625 died. COVID-19 death was associated with male sex, increasing age, diabetes, hypertension, and chronic kidney disease. HIV was associated with COVID-19 mortality (adjusted hazard ratio [aHR], 2.14; 95% confidence interval [CI], 1.70-2.70), with similar risks across strata of viral loads and immunosuppression. Current and previous diagnoses of tuberculosis were associated with COVID-19 death (aHR, 2.70 [95% CI, 1.81-4.04] and 1.51 [95% CI, 1.18-1.93], respectively). The SMR for COVID-19 death associated with HIV was 2.39 (95% CI, 1.96-2.86); population attributable fraction 8.5% (95% CI, 6.1-11.1).
Conclusions: While our findings may overestimate HIV- and tuberculosis-associated COVID-19 mortality risks due to residual confounding, both living with HIV and having current tuberculosis were independently associated with increased COVID-19 mortality. The associations between age, sex, and other comorbidities and COVID-19 mortality were similar to those in other settings.
Keywords: COVID-19; HIV; antiretroviral; sub-Saharan Africa; tuberculosis.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures

Update of
-
HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa.medRxiv [Preprint]. 2020 Jul 3:2020.07.02.20145185. doi: 10.1101/2020.07.02.20145185. medRxiv. 2020. Update in: Clin Infect Dis. 2021 Oct 5;73(7):e2005-e2015. doi: 10.1093/cid/ciaa1198. PMID: 32637972 Free PMC article. Updated. Preprint.
Comment in
-
Coronavirus Disease 2019: First Data From Africa.Clin Infect Dis. 2021 Oct 5;73(7):e2016-e2017. doi: 10.1093/cid/ciaa1293. Clin Infect Dis. 2021. PMID: 32865552 Free PMC article. No abstract available.
References
-
- Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis 2020. [Preprint]. May 14, 2020. doi: 10.1093/cid/ciaa579. Accessed 1 June 2020. - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical